Stryker Net Profit Margin 2010-2024 | SYK

Current and historical net profit margin for Stryker (SYK) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Stryker net profit margin for the three months ending September 30, 2024 was .
Stryker Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $21.97B $3.59B 16.34%
2024-06-30 $21.39B $3.45B 16.12%
2024-03-31 $20.96B $3.36B 16.03%
2023-12-31 $20.50B $3.17B 15.44%
2023-09-30 $19.89B $2.59B 13.00%
2023-06-30 $19.46B $2.71B 13.92%
2023-03-31 $18.95B $2.63B 13.86%
2022-12-31 $18.45B $2.36B 12.78%
2022-09-30 $17.95B $2.46B 13.69%
2022-06-30 $17.63B $2.08B 11.79%
2022-03-31 $17.43B $2.02B 11.56%
2021-12-31 $17.11B $1.99B 11.66%
2021-09-30 $16.67B $1.90B 11.40%
2021-06-30 $16.25B $2.08B 12.82%
2021-03-31 $14.72B $1.41B 9.57%
2020-12-31 $14.35B $1.60B 11.14%
2020-09-30 $14.22B $1.76B 12.35%
2020-06-30 $14.07B $1.60B 11.38%
2020-03-31 $14.96B $2.16B 14.47%
2019-12-31 $14.88B $2.08B 13.99%
2019-09-30 $14.55B $3.43B 23.55%
2019-06-30 $14.20B $3.55B 24.99%
2019-03-31 $13.88B $3.52B 25.38%
2018-12-31 $13.60B $3.55B 26.12%
2018-09-30 $13.28B $1.24B 9.31%
2018-06-30 $13.04B $1.08B 8.28%
2018-03-31 $12.73B $1.02B 8.00%
2017-12-31 $12.44B $1.02B 8.20%
2017-09-30 $12.13B $1.78B 14.67%
2017-06-30 $11.96B $1.70B 14.22%
2017-03-31 $11.79B $1.69B 14.33%
2016-12-31 $11.33B $1.65B 14.54%
2016-09-30 $10.88B $1.66B 15.24%
2016-06-30 $10.47B $1.61B 15.33%
2016-03-31 $10.06B $1.62B 16.07%
2015-12-31 $9.95B $1.44B 14.47%
2015-09-30 $9.85B $1.18B 11.95%
2015-06-30 $9.82B $0.93B 9.50%
2015-03-31 $9.75B $0.67B 6.86%
2014-12-31 $9.68B $0.52B 5.32%
2014-09-30 $9.53B $0.64B 6.73%
2014-06-30 $9.29B $0.69B 7.40%
2014-03-31 $9.14B $0.77B 8.45%
2013-12-31 $9.02B $1.01B 11.15%
2013-09-30 $8.89B $0.89B 10.01%
2013-06-30 $8.79B $1.14B 12.97%
2013-03-31 $8.69B $1.25B 14.41%
2012-12-31 $8.66B $1.30B 14.99%
2012-09-30 $8.53B $1.43B 16.74%
2012-06-30 $8.51B $1.40B 16.48%
2012-03-31 $8.45B $1.39B 16.42%
2011-12-31 $8.31B $1.35B 16.19%
2011-09-30 $8.09B $1.24B 15.32%
2011-06-30 $7.82B $1.25B 15.96%
2011-03-31 $7.54B $1.26B 16.69%
2010-12-31 $7.32B $1.27B 17.39%
2010-09-30 $7.16B $1.28B 17.94%
2010-06-30 $7.04B $1.18B 16.70%
2010-03-31 $6.92B $1.15B 16.59%
2009-12-31 $6.72B $1.11B 16.47%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $146.166B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.826B 25.11
Boston Scientific (BSX) United States $145.408B 41.81
EssilorLuxottica (ESLOY) France $115.383B 0.00
Medtronic (MDT) Ireland $112.944B 16.78
Lonza Group Ag (LZAGY) Switzerland $43.849B 0.00
Haleon (HLN) United Kingdom $41.827B 27.18
GE HealthCare Technologies (GEHC) United States $38.715B 20.08
ResMed (RMD) United States $35.199B 28.92
Terumo (TRUMY) Japan $27.980B 0.00
Koninklijke Philips (PHG) Netherlands $24.250B 18.56
Zimmer Biomet Holdings (ZBH) United States $21.811B 13.89
Insulet (PODD) United States $19.347B 77.04
Baxter (BAX) United States $15.818B 10.29
Smith & Nephew SNATS (SNN) United Kingdom $11.057B 0.00
Bio-Rad Laboratories (BIO) United States $9.586B 32.58
BellRing Brands (BRBR) United States $9.323B 37.51
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.360B 14.78
ICU Medical (ICUI) United States $4.012B 38.20
Prestige Consumer Healthcare (PBH) United States $3.882B 19.31
Haemonetics (HAE) United States $3.691B 18.01
Envista Holdings (NVST) United States $3.413B 25.42
Perrigo (PRGO) Ireland $3.252B 9.57
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.807B 18.07
GN Store Nord (GNNDY) Denmark $2.585B 16.58
Neogen (NEOG) United States $2.508B 28.90
LeMaitre Vascular (LMAT) United States $2.227B 54.13
AtriCure (ATRC) United States $1.876B 0.00
Green Thumb Industries (GTBIF) United States $1.572B 27.52
AdaptHealth (AHCO) United States $1.416B 10.11
InMode (INMD) Israel $1.410B 8.48
BioLife Solutions (BLFS) United States $1.213B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.205B 0.00
Owens & Minor (OMI) United States $1.124B 8.78
Curaleaf Holdings (CURLF) Canada $0.981B 0.00
Phibro Animal Health (PAHC) United States $0.843B 14.87
CeriBell (CBLL) United States $0.754B 0.00
Evolus (EOLS) United States $0.666B 0.00
Capricor Therapeutics (CAPR) United States $0.623B 0.00
VAREX IMAGING (VREX) United States $0.557B 24.58
Omeros (OMER) United States $0.541B 0.00
Surmodics (SRDX) United States $0.527B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.434B 0.00
ZimVie (ZIMV) United States $0.394B 33.23
Valneva SE (VALN) France $0.355B 0.00
Quanterix (QTRX) United States $0.342B 0.00
Cerus (CERS) United States $0.332B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.18
Biote (BTMD) United States $0.306B 6.71
Sanara MedTech (SMTI) United States $0.285B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.25
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.245B 51.20
Canopy Growth (CGC) Canada $0.237B 0.00
Sanuwave Health (SNWV) United States $0.226B 3.18
Aurora Cannabis (ACB) Canada $0.211B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.56
Organigram Holdings (OGI) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.192B 102.30
MacroGenics (MGNX) United States $0.188B 0.00
TerrAscend (TSNDF) Canada $0.168B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.149B 18.77
Veru (VERU) United States $0.143B 0.00
Jin Medical (ZJYL) China $0.143B 0.00
Quipt Home Medical (QIPT) United States $0.130B 0.00
Fonar (FONR) United States $0.096B 10.87
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
INLIF (INLF) $0.078B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.070B 0.00
Rockwell Medical (RMTI) United States $0.069B 35.33
Jushi Holdings (JUSHF) United States $0.063B 0.00
Ayr Wellness (AYRWF) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.11
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00